NCT03589287View on ClinicalTrials.gov

Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

May 3, 2019

Study Completion Date

April 30, 2020

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Chondrochymal®

Allogeneic Bone Marrow Derived Mesenchymal Stem Cells

Trial Locations (1)

Unknown

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

Virginia Contract Research Organization Co., Ltd.

OTHER

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT03589287 - Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter